COMPLERA - 54868-6360-0 - (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)

Alphabetical Index


Drug Information of COMPLERA

Product NDC: 54868-6360
Proprietary Name: COMPLERA
Non Proprietary Name: emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
Active Ingredient(s): 200; 25; 300    mg/1; mg/1; mg/1 & nbsp;   emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of COMPLERA

Product NDC: 54868-6360
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202123
Marketing Category: NDA
Start Marketing Date: 20130201

Package Information of COMPLERA

Package NDC: 54868-6360-0
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (54868-6360-0)

NDC Information of COMPLERA

NDC Code 54868-6360-0
Proprietary Name COMPLERA
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (54868-6360-0)
Product NDC 54868-6360
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130201
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
Strength Number 200; 25; 300
Strength Unit mg/1; mg/1; mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Non-Nucleoside Analog [Chemical/Ingredient],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of COMPLERA


General Information